Lypazyme
On sale on the US market (according to the DSLD)
Houston Enzymes, food supplement from the US market
Lypazyme (Houston Enzymes), a food supplement au code-barres 898631000427, is described by its US market label. The French and European rules we can apply to this label flag no particular point. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
No point flagged by the rules we apply.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Houston Enzymes
- Barcode
- 898631000427
- Form
- Capsule
- One serving
- 1 capsule
- Servings
- number of servings per day not stated
- Other ingredients (in English, as written)
- Microcrystalline Cellulose, Hypromellose, Water
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Lypazyme Blend | Blend | 40 mg |
| Lipase 1 | Enzyme | not stated |
| Lipase 2 | Enzyme | not stated |
| Lipase 3 | Enzyme | not stated |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Lypazyme
Entered into DSLD on 21 November 2020. Withdrawn from the US market on 28 July 2022 (according to the DSLD).- Active ingredient added : Lipase I (quantity not stated)
- Active ingredient added : Lipase II (quantity not stated)
- Active ingredient added : Lipase III (quantity not stated)
- Active ingredient removed : Lipase 1 (quantity not stated)
- Active ingredient removed : Lipase 2 (quantity not stated)
- Active ingredient removed : Lipase 3 (quantity not stated)
Official label: Lypazyme
Entered into DSLD on 23 May 2014. Withdrawn from the US market on 12 August 2020 (according to the DSLD).- Active ingredient added : Lipase I (250 FIP)
- Active ingredient added : Lipase II (600 FIP)
- Active ingredient added : Lipase III (150 FIP)
- Active ingredient removed : Lipase 1 (quantity not stated)
- Active ingredient removed : Lipase 2 (quantity not stated)
- Active ingredient removed : Lipase 3 (quantity not stated)
- Same quantity, different name: LipaZyme in this version; Lypazyme Blend on the displayed label (40 mg)
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : Houston Enzymes
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Lypazyme (Houston Enzymes): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/898631000427-lypazyme-houston-enzymes, updated 23 August 2023.